Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
Research interests: nanoparticles in medicine; therapeautic applications; targeted drug delivery
Professor Frank Gu received his PhD at Queen’s University in Canada, where he majored in chemical engineering and was awarded with Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC).
During his PhD program, he was awarded the Japanese Society the Promotion of Science (JSPS) summer fellowship to work under the supervision of Professor Kazunori Kataoka at the University of Tokyo in Japan.
In 2006, he was award with NSERC Postdoctoral Fellowship to join the Institute Professor Robert Langer laboratory at Massachusetts Institute of Technology (MIT).
In July 2008, Gu joined Department of Chemical Engineering at the University of Waterloo. His current research interests are in the development of biomaterials for nanomedicine and biopharmaceutics applications.
Our laboratory specializes in the development of self-assembled polymeric nanoparticles for the delivery of conventional small molecule therapeutic agents. Our technology aims to improve the therapeutic index of currently available drugs by optimizing their efficacy and toxicity, and to improve the solubility and stability of drug entities that have been stalled in preclinical trials because of suboptimal biochemical properties.
The central challenge in administering polymeric nanoparticles in vivo lies in the rapid particle clearance from the systemic circulation by the liver and spleen. As a result, only a small fraction of the administered nanoparticle dose is able to reach the targeted diseased cells and tissues. The nanoparticle clearance process is initiated when blood plasma proteins bind to the particle surface, making them visible to macrophages.
We propose that the rate of nanoparticle clearance by macrophages can be substantially decreased by systematically optimizing the surface properties of polymeric nanoparticles. We are developing a high-throughput combinatorial screening technique for studying the nanoparticle physicochemical properties to minimize blood protein adsorption on the particle surface.
Our lab also specializes in designing and optimizing the processes in nanoparticle manufacturing, which include particle formation, collection, drying and sterilization.
Recent publications include:
Please see Frank Gu's Google Scholar profile for a current list of his peer-reviewed articles.
Office: QNC 4602
Phone: 519-888-4567, ext.38605
Email: frank.gu@uwaterloo.ca
Personal Website: Frank Gu
Waterloo Institute for Nanotechnology
Mike & Ophelia Lazaridis Quantum-Nano Centre, QNC 3606
University of Waterloo
200 University Avenue West,
Waterloo, ON N2L 3G1
519-888-4567, ext. 38654
win-office@uwaterloo.ca
The University of Waterloo acknowledges that much of our work takes place on the traditional territory of the Neutral, Anishinaabeg and Haudenosaunee peoples. Our main campus is situated on the Haldimand Tract, the land granted to the Six Nations that includes six miles on each side of the Grand River. Our active work toward reconciliation takes place across our campuses through research, learning, teaching, and community building, and is co-ordinated within the Office of Indigenous Relations.